Heraeus expands its platinum-based HPAPI capacity
Company's multimillion euro investment will enable it to meet growing market demands from clients providing cancer treatments.
Heraeus Pharmaceutical Ingredients, a business line of Heraeus Precious Metals, has expanded its capacity for platinum-based highly potent active pharmaceutical ingredients (HPAPIs) with an additional production line built at the company’s headquarters in Hanau, Germany.
Heraeus is the leading market supplier for Platinum-based HPAPIs, which are a key component used in cancer chemotherapy. As cancer cases rise across the globe, Heraeus has increased its production capabilities to ensure it leads the drive for much-needed capacity to meet the long-term global market demand.
The technical set-up of the new production line is now complete and commercial production is scheduled to begin in 2020 upon completion of the validation process.
Dr Marcus Hannakam, Head of Heraeus’ Pharmaceutical Ingredients Business Line said: “This multimillion euro investment in additional capacity underlines our commitment to lead in this field and help our customers in the vital job of providing the drugs to treat cancer patients across the globe.
“We have a proud tradition in high-quality precious metal technologies and a continued focus on fostering long-term partnerships with our customers who work on therapies to fight cancer.
“With the technical set-up of our new production line now complete, we are primed and ready to meet the growing market demands from our clients for platinum-based HPAPIs and lifesaving treatments for cancer patients.”
Platinum-based HPAPIs are used in chemotherapy treatments to combat a range of cancers, including lung, colorectal, ovarian and testicular cancer. The need for these particular HPAPIs in cancer treatment has been rocketing due to demographic changes leading to more cancer cases, emerging countries gaining access to chemotherapy and usage of platinum-based HPAPIs in combination therapy.
Related News
-
News Eli Lilly gets ready to launch five new drugs in 2023
Eli Lilly, the American pharmaceutical company (IN, USA) are gearing up for a big year ahead, with hopes to launch five new drugs and capitalise on growing obesity and Alzheimer’s disease markets. -
News Amgen buys Horizon for $27.8 billion in bold step into the rare disease market
Amgen Inc buys pharmaceutical company Horizon Therapeutics in a multibillion-dollar deal, in hopes to capitalise on it's portfolio of drugs in the highly sort after rare disease market. -
News Pharma Supply Chain People Moves
The latest appointments and promotions across the pharmaceutical supply chain. -
News Merck to donate new Ebola vaccine to defend against outbreaks in Uganda
Pharmaceutical giant Merck has announced they will be speeding up the processing of a new vaccine against the latest strain of the Ebola virus, to be donated to a global non-profit organisation for distribution -
News CPHI Podcast Series: Driving innovation with pharmaceutical startups
The latest episode in the CPHI Podcast Series explores how startups are driving innovation by taking high-risk approaches and doing business with greater agility. -
News Greener and efficient processes: Quaternary Ammonium Salts
Quaternary Ammonium Salts play a crucial part in Organic Chemistry processes at many major industries. Discover why.
-
News Biosimilars save patients $11B annually, but barriers to adoption remain in US market
Biosimilars introduce competition into the biologics market, driving down prices and increasing patient access. -
News WHO recommends use of two monoclonal antibody treatments against Ebola
The health body recommended use of treatments by Regeneron and Ridgeback Bio
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance